Stifel’s $235 target on RMD

RMD ResMed

$219 → $235 (+7%) by Oct 2027

Hold · reiterates · said Oct 2, 2026 · 12-month default horizon

Open: judged on the close on Oct 2, 2027

The article this target came from

Stifel reiterates Hold on ResMed stock amid market share concerns

Investing.com · Oct 2, 2026

Stifel maintained a Hold rating on ResMed Inc. (NYSE:RMD) with a $235.00 price target on Friday, citing potential market share pressures from a possible competitor reentry.

Stifel’s track record → ResMed →

A fact about what Stifel published, as reported by Investing.com, not a recommendation from Dalsna Finance; Stifel is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.